Dr. Tanya Ermolovich, DO

Dr. Ermolovich practices at Lackawanna Valley Dermatology Associates Limited in Kingston, Pennsylvania.

Dr. Ermolovich's NPI, 1881681971, was assigned on October 4, 2005. Dr. Ermolovich graduated from Pcom in 1995. Dr. Ermolovich holds Pennsylvania license OS009218L.

Dr. Ermolovich's primary practice is Lackawanna Valley Dermatology Associates Limited, at 440 Pierce St, Kingston, PA 18704 in Luzerne County. The practice phone is (570) 961-5522.

Dr. Ermolovich's primary practice is Lackawanna Valley Dermatology Associates Limited in Kingston, Pennsylvania. Dr. Ermolovich is also affiliated with Wilkes-Barre General Hospital. The medical group on file is Lackawanna Valley Dermatology Associates. Dmand AI also links Dr. Ermolovich to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ermolovich practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Ermolovich's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Ermolovich is board certified in 1996 - 2026 by the PA State License. Dr. Ermolovich is licensed in Pennsylvania.

Dmand AI lists acute skin infection, benign or precancerous skin growths, contact dermatitis, itchy rashes, joint cyst, minor head injury, minor injury on trunk and psoriasis among the conditions Dr. Ermolovich treats.

CMS data shows 2,959 Medicare services from Dr. Ermolovich across 14 procedure codes in 2024, for 971 Medicare patients. Medicare paid $165,406 for them. Every service was in an office.

CMS counts 971 Medicare patients who saw Dr. Ermolovich in 2024. The largest group is 65 to 74, with 478 patients. 75% of them have high cholesterol, and 67% have high blood pressure. Their average risk score is 0.91, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ermolovich's median patient age at 69, with 67% women.

In 2024, Dr. Ermolovich wrote 1,423 Medicare Part D claims for 560 patients. 94% of them were for generic drugs. CMS names the drug for 1,297 of them, across 19 drugs with 11 or more claims each, at $36,137 in total drug cost. In 2023, CMS named 1,218 claims across 15 drugs.

Dr. Ermolovich accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 127 procedures of skin biopsy by Dr. Ermolovich, more than 79% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Ermolovich, published from 2008 to 2019. 2019 was the busiest year, with 2. The most frequent topics are Skin Neoplasms, Diagnosis, Differential and Carcinoma, Basal Cell. Dr. Ermolovich has published most often in Cutis. Dr. Ermolovich's most frequent co-authors are Stephen M. Purcell, DO, Carl J. Barrick, DO and Claire Otteni Dorfman, DO.

CMS Open Payments shows 85 general payments to Dr. Ermolovich from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Amgen Inc. paid the most, $2,347.

Dmand AI lists 2 awards for Dr. Ermolovich, most recently CMS Stage 1 EHR in 2013.

Dr. Ermolovich graduated from Pcom in 1995. Dr. Ermolovich is a member of AAD.

Dr. Ermolovich is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.